
Glaukos Corporation GKOS
$ 119.29
0.28%
Quarterly report 2025-Q2
added 08-04-2025
Glaukos Corporation Total Current Liabilities 2011-2026 | GKOS
Annual Total Current Liabilities Glaukos Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74 M | 72.4 M | 63.4 M | 49.7 M | 57.7 M | 30.4 M | 26.8 M | 16.9 M | 20.4 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 74 M | 16.9 M | 45.7 M |
Total Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.6 K | - | - | $ 810 M | ||
|
Baxter International
BAX
|
6.51 B | $ 20.1 | 1.85 % | $ 10.3 B | ||
|
Luminex Corporation
LMNX
|
87.5 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | ||
|
ICU Medical
ICUI
|
556 M | $ 148.85 | -0.79 % | $ 3.63 B | ||
|
Antares Pharma, Inc.
ATRS
|
63.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
179 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
11.8 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
952 M | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
1.85 B | - | -0.02 % | $ 16.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
7.54 M | $ 8.57 | 2.15 % | $ 173 M | ||
|
Repro Med Systems
KRMD
|
4.45 M | $ 5.39 | -1.1 % | $ 246 M | ||
|
AtriCure
ATRC
|
73.4 M | $ 36.9 | -0.14 % | $ 1.73 B | ||
|
Haemonetics Corporation
HAE
|
578 M | $ 66.55 | 0.88 % | $ 3.35 B | ||
|
electroCore
ECOR
|
8.12 M | $ 6.6 | -7.04 % | $ 36.4 K | ||
|
AngioDynamics
ANGO
|
76.2 M | $ 10.3 | 3.21 % | $ 421 M | ||
|
InfuSystem Holdings
INFU
|
14.5 M | $ 8.27 | 2.73 % | $ 171 M | ||
|
OraSure Technologies
OSUR
|
33.5 M | $ 2.78 | -0.54 % | $ 207 M | ||
|
The Cooper Companies
COO
|
1.11 B | $ 81.34 | 1.21 % | $ 16.2 B | ||
|
Masimo Corporation
MASI
|
618 M | $ 137.49 | 0.91 % | $ 7.33 B | ||
|
Harvard Bioscience
HBIO
|
26.5 M | $ 0.5 | -6.73 % | $ 21.2 M | ||
|
Merit Medical Systems
MMSI
|
216 M | $ 80.93 | 0.85 % | $ 4.71 B | ||
|
Isoray
ISR
|
18.2 M | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
111 M | $ 154.21 | 3.5 % | $ 4.81 B | ||
|
LeMaitre Vascular
LMAT
|
30.6 M | $ 84.97 | 1.32 % | $ 1.91 B | ||
|
STERIS plc
STE
|
1.02 B | $ 261.9 | 0.02 % | $ 25.8 B | ||
|
Intuitive Surgical
ISRG
|
1.75 B | $ 505.17 | -0.47 % | $ 179 B | ||
|
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | ||
|
Microbot Medical
MBOT
|
3.79 M | $ 1.81 | -2.96 % | $ 18.5 M | ||
|
Utah Medical Products
UTMD
|
4.71 M | $ 61.21 | -0.71 % | $ 222 M | ||
|
Nephros
NEPH
|
2.11 M | $ 4.35 | -0.91 % | $ 45.2 M | ||
|
Milestone Scientific
MLSS
|
3.74 M | $ 0.29 | -2.67 % | $ 23.1 M | ||
|
Envista Holdings Corporation
NVST
|
879 M | $ 23.4 | 0.13 % | $ 4.03 B | ||
|
Pro-Dex
PDEX
|
14.6 M | $ 38.77 | -1.61 % | $ 127 M | ||
|
Predictive Oncology
POAI
|
3.59 M | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
6.71 M | $ 13.76 | 0.99 % | $ 661 M | ||
|
Becton, Dickinson and Company
BDX
|
8.31 B | $ 203.2 | 1.05 % | $ 58.5 B | ||
|
Repligen Corporation
RGEN
|
165 M | $ 150.44 | -3.8 % | $ 8.38 M | ||
|
ResMed
RMD
|
689 M | $ 256.15 | -0.57 % | $ 37.4 B | ||
|
BioLife Solutions
BLFS
|
32.7 M | $ 21.91 | -2.97 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
13.2 M | $ 2.21 | -5.36 % | $ 178 M | ||
|
Retractable Technologies
RVP
|
8.78 M | $ 0.7 | -1.03 % | $ 21 M | ||
|
STAAR Surgical Company
STAA
|
70.3 M | $ 18.9 | -0.24 % | $ 928 M | ||
|
Teleflex Incorporated
TFX
|
649 M | $ 104.44 | -0.96 % | $ 4.89 B | ||
|
West Pharmaceutical Services
WST
|
550 M | $ 231.57 | -0.4 % | $ 16.9 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.59 B | $ 12.47 | 1.63 % | $ 2.53 B |